The Cooper Companies found using ticker (COO) now have 11 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The target price ranges between 560 and 335 calculating the average target price we see 425.55. Given that the stocks previous close was at 332.35 this now indicates there is a potential upside of 28.0%. The 50 day MA is 365.99 and the 200 moving average now moves to 399.69. The market capitalisation for the company is $15,795m. Visit the company website at: https://www.coopercos.com
The potential market cap would be $20,224m based on the market concensus.
The Cooper Companies, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women’s health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies was founded in 1958 and is headquartered in San Ramon, California.
